Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses O Oyewumi

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Drug Delivery and Translational Research|August 13, 2020
Overcoming barriers confronting application of protein therapeutics in bone fracture healingTori Czech, Moses O Oyewumi
Journal of Biomedical Nanotechnology|April 21, 2012
Antitumor effect of novel gallium compounds and efficacy of nanoparticle-mediated gallium delivery in lung cancerDaniel Wehrung, Moses O Oyewumi
Journal of Drug Delivery|September 26, 2013
Critical assessment of implantable drug delivery devices in glaucoma managementDharani Manickavasagam, Moses O Oyewumi
International Journal of Pharmaceutics|September 13, 2019
Internalization of particulate delivery systems by activated microglia influenced the therapeutic efficacy of simvastatin repurposing for neuroinflammationDharani Manickavasagam, Moses O Oyewumi
Bioconjugate Chemistry|November 21, 2002
Engineering tumor-targeted gadolinium hexanedione nanoparticles for potential application in neutron capture therapyMoses O Oyewumi, Russell J Mumper
International Journal of Pharmaceutics|January 16, 2003
Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticlesMoses O Oyewumi, Russell J Mumper
Drug Development and Industrial Pharmacy|May 25, 2002
Gadolinium-loaded nanoparticles engineered from microemulsion templatesMoses O Oyewumi, Russell J Mumper
Nanomedicine : Nanotechnology, Biology, and Medicine|October 27, 2019
Nose-to-brain co-delivery of repurposed simvastatin and BDNF synergistically attenuates LPS-induced neuroinflammationDharani Manickavasagam, Li Lin, Moses O Oyewumi
Pharmaceutical Development and Technology|April 28, 2015
Gelucire-stabilized nanoparticles as a potential DNA delivery systemMoses O Oyewumi, Daniel Wehrung, Prabodh Sadana
AAPS Pharmscitech|February 17, 2019
Delivery Systems as Vital Tools in Drug RepurposingTori Czech, Reza Lalani, Moses O Oyewumi
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Drug Delivery and Translational Research|August 13, 2020
Overcoming barriers confronting application of protein therapeutics in bone fracture healingTori Czech, Moses O Oyewumi
Journal of Biomedical Nanotechnology|April 21, 2012
Antitumor effect of novel gallium compounds and efficacy of nanoparticle-mediated gallium delivery in lung cancerDaniel Wehrung, Moses O Oyewumi
Journal of Drug Delivery|September 26, 2013
Critical assessment of implantable drug delivery devices in glaucoma managementDharani Manickavasagam, Moses O Oyewumi
International Journal of Pharmaceutics|September 13, 2019
Internalization of particulate delivery systems by activated microglia influenced the therapeutic efficacy of simvastatin repurposing for neuroinflammationDharani Manickavasagam, Moses O Oyewumi
Bioconjugate Chemistry|November 21, 2002
Engineering tumor-targeted gadolinium hexanedione nanoparticles for potential application in neutron capture therapyMoses O Oyewumi, Russell J Mumper
International Journal of Pharmaceutics|January 16, 2003
Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticlesMoses O Oyewumi, Russell J Mumper
Drug Development and Industrial Pharmacy|May 25, 2002
Gadolinium-loaded nanoparticles engineered from microemulsion templatesMoses O Oyewumi, Russell J Mumper
Nanomedicine : Nanotechnology, Biology, and Medicine|October 27, 2019
Nose-to-brain co-delivery of repurposed simvastatin and BDNF synergistically attenuates LPS-induced neuroinflammationDharani Manickavasagam, Li Lin, Moses O Oyewumi
Pharmaceutical Development and Technology|April 28, 2015
Gelucire-stabilized nanoparticles as a potential DNA delivery systemMoses O Oyewumi, Daniel Wehrung, Prabodh Sadana
AAPS Pharmscitech|February 17, 2019
Delivery Systems as Vital Tools in Drug RepurposingTori Czech, Reza Lalani, Moses O Oyewumi
Pageof 4